These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 111488)

  • 1. The stimulation of a T cell response in the syngeneic host by the P-815 mastocytoma cell and the isolation of a tumor-associated antigen which has some H-2 antigen characteristics.
    Bertschmann M; Clemetson KJ; Lüscher EF
    Adv Exp Med Biol; 1979; 114():751-6. PubMed ID: 111488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of in vivo and in vitro immune reactions against the intradermally developing P-815 mastocytoma in the syngeneic mouse.
    Bertschmann M; Schären B; Lüscher EF
    Immunobiology; 1980 Jan; 156(4-5):382-99. PubMed ID: 6768671
    [No Abstract]   [Full Text] [Related]  

  • 3. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
    Boon T; Van Snick J; Van Pel A; Uyttenhove C; Marchand M
    J Exp Med; 1980 Nov; 152(5):1184-93. PubMed ID: 6776227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL; Van Snick J; Cerottini JC; Boon T
    Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. I. Morphometric assessment of lymph node immunoreactivity and analysis of circulating antibodies.
    Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
    Exp Pathol; 1986; 30(2):65-74. PubMed ID: 3096773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous immune rejection of intraocular tumors in mice.
    Niederkorn JY; Meunier PC
    Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):877-84. PubMed ID: 3924853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and properties of antisera directed against antigens of the P-815 mastocytoma cell not shared by its syngeneic host, the DBA/2 mouse.
    Bertschmann M; Clemetson KJ; Lüscher EF
    Eur J Cancer (1965); 1976 Apr; 12(4):255-62. PubMed ID: 60238
    [No Abstract]   [Full Text] [Related]  

  • 11. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation and partial characterization of a tumor-associated antigen of the P815 mastocytoma of DBA/2 mice.
    Al-Rammahy AK; Levy JG; Jackson AL
    J Immunol; 1980 Jan; 124(1):143-50. PubMed ID: 6765966
    [No Abstract]   [Full Text] [Related]  

  • 13. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
    Van den Eynde B; Lethé B; Van Pel A; De Plaen E; Boon T
    J Exp Med; 1991 Jun; 173(6):1373-84. PubMed ID: 1903428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
    Biddison WE; Palmer JC
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Neoplasma; 1987; 34(4):431-9. PubMed ID: 3116439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of a tumor-specific T suppressor factor from a T cell hybridoma.
    Steele JK; Stammers AT; Levy JG
    J Immunol; 1985 Apr; 134(4):2767-78. PubMed ID: 2579156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-associated antigens of the mouse P-815 mastocytoma cell: evidence for an antigen with H-2-like characteristics.
    Clemetson KJ; Bertschmann M; Lüscher EF
    Mol Immunol; 1981 Feb; 18(2):135-41. PubMed ID: 6167852
    [No Abstract]   [Full Text] [Related]  

  • 19. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.
    Uyttenhove C; Maryanski J; Boon T
    J Exp Med; 1983 Mar; 157(3):1040-52. PubMed ID: 6187879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.